Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis
Advanced Science · 2026-04 · 13 (23)
DOI: 10.1002/advs.202524002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.03.2026. Verfasst von Buying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing, China. Hauptthemen laut MEDLINE: Microbubbles, Macrophages, Receptors, CCR2, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing, Southwest Hospital Excellent Doctor Foundation, Luo Gaoxing Expert Workstation in Yunnan Province.
Abstract (Originalsprache)
The clinical management of thrombosis, a primary cause of death worldwide, is hampered by the limitations of current thrombolytic agents, including short half‐life and high risk of off‐target bleeding. Here, we report the design and validation of an intelligent, inflammation‐targeting microbubble for precise thrombolysis. We first engineered macrophages to overexpress the C─C chemokine receptor 2 (CCR2) via lentiviral transfection. Membranes derived from these cells were then used to functionalize a liposomal structure, co‐encapsulating the thrombolytic drug urokinase (UK) and a phase‐change perfluoropropane gas. These resulting biomimetic microbubbles (termed UK@CCR2/MBs) were designed to navigate the vasculature and home in on thrombotic sites by binding to the highly expressed monocyte chemoattractant protein‐1 (MCP‐1) via the CCR2 receptor. Upon arrival at the target, localized low‐frequency ultrasound was applied to trigger acoustic droplet vaporization, leading to microbubble disruption and spatiotemporally controlled UK release. Extensive in vitro and in vivo evaluations, including in animal models of deep vein, carotid artery, and microcirculatory thrombosis, confirmed that UK@CCR2/MBs achieve superior thrombolytic efficacy and specific targeting with an excellent safety profile. This macrophage‐mimicking, ultrasound‐responsive system represents a sophisticated theranostic platform for the non‐invasive and targeted treatment of thrombotic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing, China.
- College of Bioengineering, Chongqing University, Chongqing, China.
- Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON, Canada.
- Department of Mechanical Engineering, University of Manitoba, Winnipeg, MB, Canada.
ORCID-Profile: Kibret Mequanint, Malcolm Xing
Förderung
- Natural Science Foundation of Chongqing
- Southwest Hospital Excellent Doctor Foundation
- Luo Gaoxing Expert Workstation in Yunnan Province
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Li, B., Lu, C., Gao, S., Chen, D., Heng, X., Mequanint, K., Xing, M., Luo, G., & Li, H. (2026). Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis. Advanced Science, 13(23). https://doi.org/10.1002/advs.202524002
Vancouver
Li B, Lu C, Gao S, Chen D, Heng X, Mequanint K, et al. Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis. Advanced Science. 2026;13(23). doi:10.1002/advs.202524002
BibTeX
@article{Li2026,
author = {Li, Buying and Lu, Changjin and Gao, Shijie and Chen, Dandan and Heng, Xue and Mequanint, Kibret and Xing, Malcolm and Luo, Gaoxing and Li, Haisheng},
title = {Targeted Thrombolysis via CCR2‐Engineered Macrophage‐Mimicking Microbubbles Safely Ablates Venous, Arterial, and Microvascular Thrombosis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {23},
doi = {10.1002/advs.202524002}
}
EUVIMED